Argentina Prostate Cancer Diagnostics Market to 2032
Overview
The Argentina Prostate Cancer Diagnostics Market is expected to reach a 146.50 USD Million by 2032 and is projected to grow at a CAGR of 16.78% from 2025 to 2032.
Revenue, 2024 (USD Million)
55.53
Forecast, 2032 (USD Million)
146.50
CAGR, 2024 - 2032
16.78%
Report Coverage
Argentina
Argentina Prostate Cancer Diagnostics Market 2018-2032 USD Million
Argentina Prostate Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 55.53 USD Million
- Projected Market Size (2032): 146.50 USD Million
- CAGR (2025-2032): 16.78%
Key Findings of Argentina Prostate Cancer Diagnostics Market
- The Argentina Prostate Cancer Diagnostics Market was valued at 146.50 USD Million in 2024.
- The Argentina Prostate Cancer Diagnostics Market is likely to grow at a CAGR of 16.78% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prostatic Adenocarcinoma in Type Segment accounted for the largest share of the market with a revenue of 52.16 USD Million
- The fastest growing segment Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) in Stage Segment grew Fastest with a CAGR of 18.74% during the forecast period from 2024 to 2032.
Argentina Prostate Cancer Diagnostics Market Scope
Argentina Prostate Cancer Diagnostics Market Segmentation & Scope
End User
- Others
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Independent Diagnostic Laboratories
Distribution Channel
- Retail Sales
- Direct Tender
Age Group
- Pediatric
- Adult
- Geriatrics
Type
- Others
- Small Cell Carcinoma
- Prostatic Adenocarcinoma
Stage
- Recurrent/Advanced Prostate Cancer
- Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)
- Localized Prostate Cancer
Sample Type
- Others
- Urine
- Tissue
- Blood
Diagnostics Type
- Confirmatory Tests
- Preliminary Screening Tests
Product Type
- Accessories
- Instruments
- Reagents & Consumables
Argentina Prostate Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 55.53 USD Million |
| Market Value in 2032 | 146.50 USD Million |
| CAGR (2025-2032) | 16.78% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type |
Regional Insights:
-
Leading Market (2024-2032): Argentina, leading in terms of revenue 55.53 USD Million in 2024
- Key Country: Argentina, leading in terms of revenue with value of 55.53 USD Million in 2024.
Segments and Scope
-
Argentina Prostate Cancer Diagnostics Market to 2032, By End User
- Independent Diagnostic Laboratories is the largest segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a revenue of 37.17 USD Million in the year 2024.
- Independent Diagnostic Laboratories is the Fastest growing segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.20 % in forecast period 2025-2032.
-
Argentina Prostate Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a revenue of 42.94 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.69 % in forecast period 2025-2032.
-
Argentina Prostate Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a revenue of 46.27 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.09 % in forecast period 2025-2032.
-
Argentina Prostate Cancer Diagnostics Market to 2032, By Type
- Prostatic Adenocarcinoma is the largest segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a revenue of 52.16 USD Million in the year 2024.
- Prostatic Adenocarcinoma is the Fastest growing segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.90 % in forecast period 2025-2032.
-
Argentina Prostate Cancer Diagnostics Market to 2032, By Stage
- Localized Prostate Cancer is the largest segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a revenue of 40.55 USD Million in the year 2024.
- Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) is the Fastest growing segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.43 % in forecast period 2025-2032.
-
Argentina Prostate Cancer Diagnostics Market to 2032, By Sample Type
- Blood is the largest segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a revenue of 42.46 USD Million in the year 2024.
- Blood is the Fastest growing segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.18 % in forecast period 2025-2032.
-
Argentina Prostate Cancer Diagnostics Market to 2032, By Diagnostics Type
- Preliminary Screening Tests is the largest segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a revenue of 42.03 USD Million in the year 2024.
- Preliminary Screening Tests is the Fastest growing segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.40 % in forecast period 2025-2032.
-
Argentina Prostate Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a revenue of 40.35 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Argentina Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.39 % in forecast period 2025-2032.
Argentina Prostate Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| OPKO Health, Inc. | |||
| Beckman Coulter, Inc. | |||
| Abbott | |||
| F. Hoffmann-La Roche Ltd. | |||
Argentina Prostate Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Argentina Prostate Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Argentina Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
Argentina Prostate Cancer Diagnostics Market was valued at USD 55.53(Revenue in USD Million) in 2022.
Argentina Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.78% during the forecast period of 2024 to 2032.
The Prostatic Adenocarcinoma segment is expected to dominate the Argentina Prostate Cancer Diagnostics Market, holding a largest market share of 52.16 USD Million in 2024
Argentina Prostate Cancer Diagnostics Market Scope
Argentina Prostate Cancer Diagnostics Market Segmentation & Scope
End User
- Others
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Independent Diagnostic Laboratories
Distribution Channel
- Retail Sales
- Direct Tender
Age Group
- Pediatric
- Adult
- Geriatrics
Type
- Others
- Small Cell Carcinoma
- Prostatic Adenocarcinoma
Stage
- Recurrent/Advanced Prostate Cancer
- Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)
- Localized Prostate Cancer
Sample Type
- Others
- Urine
- Tissue
- Blood
Diagnostics Type
- Confirmatory Tests
- Preliminary Screening Tests
Product Type
- Accessories
- Instruments
- Reagents & Consumables
Frequently Asked Questions
The Argentina Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
Argentina Prostate Cancer Diagnostics Market was valued at USD 55.53(Revenue in USD Million) in 2022.
Argentina Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.78% during the forecast period of 2024 to 2032.
The estimated market value of the Argentina Prostate Cancer Diagnostics Market for final year is USD 146.50 (USD Million).
Argentina Prostate Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Argentina Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
Argentina Prostate Cancer Diagnostics Market was valued at USD 55.53(Revenue in USD Million) in 2022.
Argentina Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.78% during the forecast period of 2024 to 2032.
The estimated market value of the Argentina Prostate Cancer Diagnostics Market for final year is USD 146.50 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.